ES2101848T3 - Productos analogos a los tocoferoles que bajan el porcentaje de colesterol. - Google Patents

Productos analogos a los tocoferoles que bajan el porcentaje de colesterol.

Info

Publication number
ES2101848T3
ES2101848T3 ES92912113T ES92912113T ES2101848T3 ES 2101848 T3 ES2101848 T3 ES 2101848T3 ES 92912113 T ES92912113 T ES 92912113T ES 92912113 T ES92912113 T ES 92912113T ES 2101848 T3 ES2101848 T3 ES 2101848T3
Authority
ES
Spain
Prior art keywords
tocopheroles
analoged
cholesterol
percentage
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92912113T
Other languages
English (en)
Inventor
Keith M Robinson
Eric W Heineke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2101848T3 publication Critical patent/ES2101848T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

ESTA INVENCION ES RELATIVA A DERIVADOS ALQUILOAMINO ALQUILENO DE CIERTOS 2H ORES DE COLESTEROL EN PLASMA Y A SU APLICACION DE USO FINAL COMO AGENTES TERAPEUTICOS.
ES92912113T 1991-06-05 1992-05-06 Productos analogos a los tocoferoles que bajan el porcentaje de colesterol. Expired - Lifetime ES2101848T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/710,647 US5135945A (en) 1991-06-05 1991-06-05 Cholesterol-lowering tocopherol analogs

Publications (1)

Publication Number Publication Date
ES2101848T3 true ES2101848T3 (es) 1997-07-16

Family

ID=24854940

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92912113T Expired - Lifetime ES2101848T3 (es) 1991-06-05 1992-05-06 Productos analogos a los tocoferoles que bajan el porcentaje de colesterol.

Country Status (16)

Country Link
US (1) US5135945A (es)
EP (1) EP0586518B1 (es)
JP (1) JP3072912B2 (es)
KR (1) KR100196973B1 (es)
AT (1) ATE149830T1 (es)
AU (1) AU665353B2 (es)
CA (1) CA2102812C (es)
DE (1) DE69218196T2 (es)
DK (1) DK0586518T3 (es)
ES (1) ES2101848T3 (es)
GR (1) GR3023646T3 (es)
HU (1) HUT65738A (es)
IE (1) IE921811A1 (es)
NO (1) NO304874B1 (es)
NZ (1) NZ242982A (es)
WO (1) WO1992021336A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535283A1 (en) 1991-10-02 1993-04-07 Merrell Dow Pharmaceuticals Inc. Cardioprotective tocopherol analogs
CA2082004A1 (en) * 1991-11-20 1993-05-21 David Laffan Substituted pentaalkylchromans
CA2319131A1 (en) 1998-01-26 1999-07-29 Walter H. Moos Mitochondria protecting agents for treating mitochondria associated diseases
US6770672B1 (en) 1998-09-23 2004-08-03 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
IL142082A (en) 1998-09-23 2005-12-18 Res Dev Tocoflowers, tocotrinols, derivatives as a novel and other side-chain and their uses
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
RU2263672C2 (ru) * 2000-02-11 2005-11-10 Рисерч Дивелопмент Фаундейшн Токоферолы, токотриенолы, другие хроманы и производные по боковым цепям и их применение
US6436406B1 (en) * 2000-06-15 2002-08-20 A. Glenn Braswell Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
CA2479257A1 (en) * 2002-03-21 2003-10-02 Dana-Farber Cancer Institute, Inc. Inhibition of cell death responses induced by oxidative stress

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321270A (en) * 1981-01-29 1982-03-23 E. R. Squibb & Sons, Inc. Substituted chromans
US4603142A (en) * 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
US4681890A (en) * 1984-10-30 1987-07-21 Kuraray Co., Ltd. 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs
EP0369082A1 (en) * 1988-11-14 1990-05-23 Merrell Dow Pharmaceuticals Inc. Cardioprotective tocopherol analogs
KR910007523A (ko) * 1989-10-04 1991-05-30 브리스톨-마이어즈 스퀴브 컴페니 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올

Also Published As

Publication number Publication date
IE921811A1 (en) 1992-12-16
EP0586518B1 (en) 1997-03-12
DK0586518T3 (da) 1997-04-01
GR3023646T3 (en) 1997-08-29
EP0586518A1 (en) 1994-03-16
CA2102812A1 (en) 1992-12-06
NO304874B1 (no) 1999-03-01
NZ242982A (en) 1997-03-24
KR100196973B1 (ko) 1999-06-15
JPH06508134A (ja) 1994-09-14
DE69218196T2 (de) 1997-07-17
AU1993592A (en) 1993-01-08
US5135945A (en) 1992-08-04
CA2102812C (en) 2004-03-30
AU665353B2 (en) 1996-01-04
WO1992021336A1 (en) 1992-12-10
NO934397D0 (no) 1993-12-03
KR940701251A (ko) 1994-05-28
JP3072912B2 (ja) 2000-08-07
NO934397L (no) 1993-12-03
ATE149830T1 (de) 1997-03-15
HUT65738A (en) 1994-07-28
DE69218196D1 (de) 1997-04-17

Similar Documents

Publication Publication Date Title
MX9702175A (es) Combinacion de un inhibidor de absorcion de colesterol y un inhibidor de sintesis de colesterol.
ITMI920528A1 (it) 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
DK0641343T3 (da) 4-Mercaptoacetylamino-[2]benzazepinon(3)-derivater og anvendelse som enkefalinaseinhibitorer
ES2090244T3 (es) Procedimiento para prevenir, estabilizar u ocasionar la regresion de la aterosclerosis usando una combinacion de un medicamento para disminuir el colesterol y un inhibidor de la ace.
PH30120A (en) Stable pharmaceutical composition of fumagillol derivatives
MX9303263A (es) Antagonistas de la angiotensina ii, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
MX9203385A (es) Derivados de taxol y composiciones farmaceuticas que los contienen.
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
MX9301296A (es) Nuevos compuestos de diarilsulfonamidas, procedimiento para su preparacion y formulado farmaceutico que los comprende.
ES2062943B1 (es) Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
AR240403A1 (es) Procedimiento para la esterilizacion de articulos utilizando vapor de peroxido de hidrogeno
ES2093440T3 (es) Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos.
ES2129485T3 (es) Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
MX9403915A (es) Derivados de n-alquiltio de pliamina como agentes radioprotectores.
DE69218196D1 (de) Cholesterinsenkende tocopherolanaloga
ES2071131T3 (es) Di- y tetra-fluor analogos de escualeno como inhibidores de escualeno epoxidasa.
AR002247A1 (es) Eleuterobina y analogos de la misma y composiciones que las comprenden.
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
ES2150461T3 (es) Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes.
MX9401295A (es) Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen.
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2130548T3 (es) Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 586518

Country of ref document: ES